Literature DB >> 11814645

Hydroxynonenal adducts indicate a role for lipid peroxidation in neocortical and brainstem Lewy bodies in humans.

Rudy J Castellani1, George Perry, Sandra L Siedlak, Akihiko Nunomura, Shun Shimohama, Jing Zhang, Thomas Montine, Lawrence M Sayre, Mark A Smith.   

Abstract

Multiple lines of evidence indicate that oxidative stress is a critical pathogenic factor in Parkinson disease (PD) and diffuse Lewy body disease (DLBD). Previously, we demonstrated increased levels of redox-active iron in Lewy bodies, and that Lewy bodies accumulate advanced glycation end-products. To further characterize the role of oxidative stress in diseases with Lewy body formation, we examined immunocytochemically eight cases of PD and five cases of DLBD for adducts of the lipid peroxidation adduct 4-hydroxy-2-nonenal, and for N(epsilon)-(carboxymethyl)lysine (CML). Our findings demonstrate immunolocalization of 4-hydroxynonenal and CML to Lewy bodies in PD and DLBD. These findings not only support prior studies indicating that lipid peroxidation is increased in patients with PD and DLBD but that oxidative damage may play a critical role in Lewy body formation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11814645     DOI: 10.1016/s0304-3940(01)02514-9

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  49 in total

1.  Cytoplasmic aggregates of phosphorylated extracellular signal-regulated protein kinases in Lewy body diseases.

Authors:  Jian-Hui Zhu; Scott M Kulich; Tim D Oury; Charleen T Chu
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

2.  Hydroxynonenal-generated crosslinking fluorophore accumulation in Alzheimer disease reveals a dichotomy of protein turnover.

Authors:  Xiongwei Zhu; Rudy J Castellani; Paula I Moreira; Gjumrakch Aliev; Justin C Shenk; Sandra L Siedlak; Peggy L R Harris; Hisashi Fujioka; Lawrence M Sayre; Pamela A Szweda; Luke I Szweda; Mark A Smith; George Perry
Journal:  Free Radic Biol Med       Date:  2011-11-12       Impact factor: 7.376

3.  Expression of Nrf2 in neurodegenerative diseases.

Authors:  Chenere P Ramsey; Charles A Glass; Marshall B Montgomery; Kathryn A Lindl; Gillian P Ritson; Luis A Chia; Ronald L Hamilton; Charleen T Chu; Kelly L Jordan-Sciutto
Journal:  J Neuropathol Exp Neurol       Date:  2007-01       Impact factor: 3.685

4.  Neuroinflammation, Oxidative Stress and the Pathogenesis of Parkinson's Disease.

Authors:  R Lee Mosley; Eric J Benner; Irena Kadiu; Mark Thomas; Michael D Boska; Khader Hasan; Chad Laurie; Howard E Gendelman
Journal:  Clin Neurosci Res       Date:  2006-12-06

5.  Acetyl-L-Carnitine via Upegulating Dopamine D1 Receptor and Attenuating Microglial Activation Prevents Neuronal Loss and Improves Memory Functions in Parkinsonian Rats.

Authors:  Sonu Singh; Akanksha Mishra; Neha Srivastava; Rakesh Shukla; Shubha Shukla
Journal:  Mol Neurobiol       Date:  2016-12-14       Impact factor: 5.590

6.  Intercellular transfer of pathogenic α-synuclein by extracellular vesicles is induced by the lipid peroxidation product 4-hydroxynonenal.

Authors:  Shi Zhang; Erez Eitan; Tsung-Yu Wu; Mark P Mattson
Journal:  Neurobiol Aging       Date:  2017-09-22       Impact factor: 4.673

7.  Disubstituted Dithiolethione ACDT Exerts Neuroprotective Effects Against 6-Hydroxydopamine-Induced Oxidative Stress in SH-SY5Y Cells.

Authors:  Swati Betharia; Alejandro N Rondόn-Ortiz; Dennis A Brown
Journal:  Neurochem Res       Date:  2019-06-04       Impact factor: 3.996

Review 8.  Oxidative damage to macromolecules in human Parkinson disease and the rotenone model.

Authors:  Laurie H Sanders; J Timothy Greenamyre
Journal:  Free Radic Biol Med       Date:  2013-01-15       Impact factor: 7.376

Review 9.  Molecular mechanisms of 4-hydroxy-2-nonenal and acrolein toxicity: nucleophilic targets and adduct formation.

Authors:  Richard M LoPachin; Terrence Gavin; Dennis R Petersen; David S Barber
Journal:  Chem Res Toxicol       Date:  2009-09       Impact factor: 3.739

10.  Ectopic localization of FOXO3a protein in Lewy bodies in Lewy body dementia and Parkinson's disease.

Authors:  Bo Su; Haihua Liu; Xinglong Wang; Shu G Chen; Sandra L Siedlak; Eisaku Kondo; Raymond Choi; Atsushi Takeda; Rudy J Castellani; George Perry; Mark A Smith; Xiongwei Zhu; Hyoung-Gon Lee
Journal:  Mol Neurodegener       Date:  2009-07-23       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.